Matthew Helmut Kulke is a Professor of Medicine at the Dana-Farber/Harvard Cancer Center. His work has shed light on the molecular characteristics of neuroendocrine tumors. His research has led to the development of multiple new treatments for this condition. He completed his MD at UCSF School of Medicine in 1992 and completed a master's degree in medical science at Harvard Medical School. He has an h-index of 55.